Methods of Treatment Using Interferon-Tau
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jan 31, 2008
app pub date -
Mar 9, 2005
filing date -
Mar 10, 2004
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Methods of modulating cytokine levels in a human subject by administering interferon-tau (IFN.tau.) are described. More specifically, a method of up-regulating the interleukin 10 (IL-10) level in patients afflicted with a condition that responds to treatment by having an increased blood IL-10 level, such as an autoimmune condition, a viral infection, or a condition of cellular proliferation by administering IFN.tau. is described. Also described are methods of modulating blood levels of interleukin-12 (IL-12) and interferon-gamma (IFN-.gamma.) by administering IFN.tau.. In various embodiments, IFN.tau. is administered alone or in combination with a second therapeutic agent.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully